Miraculins Announces Election of Directors
29 May 2014 - 8:30PM
Marketwired
Miraculins Announces Election of Directors
WINNIPEG, MANITOBA--(Marketwired - May 29, 2014) - Miraculins
Inc. (TSX-VENTURE:MOM) (the "Company"), a medical diagnostic
company focused on acquiring, developing and commercializing
diagnostic tests and risk assessment technologies for unmet
clinical needs, announces that at today's annual and special
meeting of shareholders (the "Meeting"), Harry Bloomfield,
Christopher Moreau, William Roberts and Michael Stasiuk were
reelected as directors of the Company to hold office until the next
annual meeting of shareholders, or until their successors are duly
elected or appointed. James Mellon had advised the Company prior to
the Meeting that he would not be standing for reelection.
Neither the TSX
Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
Miraculins Inc.Christopher J. MoreauPresident &
CEO204-477-7599204-453-1546info@miraculins.comwww.miraculins.com
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about (TSX Venture Exchange): 0 recent articles
More Miraculins Inc. News Articles